Nanoparticles-based anti-aging treatment of Alzheimer's disease
Age is the strongest risk factor for Alzheimer's disease (AD). In recent years, the relationship between aging and AD has been widely studied, with anti-aging therapeutics as the treatment for AD being one of the mainstream research directions. Therapeutics targeting senescent cells have shown...
Saved in:
Main Authors: | Jian-Jian Chu (Author), Wen-Bo Ji (Author), Jian-Hua Zhuang (Author), Bao-Feng Gong (Author), Xiao-Han Chen (Author), Wen-Bin Cheng (Author), Wen-Danqi Liang (Author), Gen-Ru Li (Author), Jie Gao (Author), You Yin (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Integrating network pharmacology and experimental validation to investigate the effects and mechanism of Renshen Shouwu decoction for ameliorating Alzheimer's disease
by: Jing-jing Liu, et al.
Published: (2024) -
The Association of Positive or Negative Religious Coping Methods With Psychological Distress and Quality of Life Among Parents of Infants With Congenital Heart Disease
by: Jian-Feng Liu, et al.
Published: (2021) -
Bibliometric and visualized analysis of ultrasound combined with microbubble therapy technology from 2009 to 2023
by: Bin Tu, et al.
Published: (2024) -
Quercetin Attenuates Cardiac Hypertrophy by Inhibiting Mitochondrial Dysfunction Through SIRT3/PARP-1 Pathway
by: Wen-Jing Chen, et al.
Published: (2021) -
Roll-out of vaccination against COVID-19 pandemic
by: Xiao-Feng Liang, et al.
Published: (2021)